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Abstract
Compared to gold-standard measurements of cerebral perfusion with positron emission
tomography (PET) using H2[15O] tracers, measurements with dynamic susceptibility contrast
(DSC) MR are more accessible, less expensive and less invasive. However, existing methods for
analyzing and interpreting data from DSC MR have characteristic disadvantages that include
sensitivity to incorrectly modeled delay and dispersion in a single, global arterial input function
(AIF). We describe a model of tissue microcirculation derived from tracer kinetics which
estimates for each voxel a unique, localized AIF (LAIF). Parameters of the model were estimated
using Bayesian probability theory and Markov-chain Monte Carlo, circumventing difficulties
arising from numerical deconvolution. Applying the new method to imaging studies from a cohort
of fourteen patients with chronic, atherosclerotic, occlusive disease showed strong correlations
between perfusion measured by DSC MR with LAIF and perfusion measured by quantitative PET
with H2[15O]. Regression to PET measurements enabled conversion of DSC MR to a
physiological scale. Regression analysis for LAIF gave estimates of a scaling factor for
quantitation which described perfusion accurately in patients with substantial variability in
hemodynamic impairment.
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Accurate measurement of cerebral hemodynamics advances our understanding of normal
and abnormal brain physiology, but remains a difficult research and clinical challenge (1).
Many common disorders of the brain, including stroke and neoplasm, manifest through
hemodynamic abnormalities and could be better diagnosed and treated with more accurate
measurements (2,3).
The gold standard for quantitative, cerebral hemodynamic measurement is positron emission
tomography (PET) using H2[15O] for cerebral blood flow (CBF) and C[15O] for cerebral
blood volume (CBV). However, PET is not as widely available as magnetic resonance (MR)
imaging and unlike MR entails significant radiation exposure to the patient (4,5). Following
the pioneering work by Østergaard, et al. (6,7) cerebral hemodynamics measurements using
dynamic susceptibility contrast (DSC) MR have become widely available on clinical
scanners and have demonstrated early promise of clinical utility (2). Many variations of this
method have been proposed (8–14) but few have been validated against a gold standard.
Additionally, DSC MR methods yield relative measurements which require scaling to obtain
quantitative physiologic values. This is typically done by assigning normal-appearing white
matter a flow value of 20–22 mL/min/100 g of tissue (15).
Most clinical implementations of the DSC method require the selection of a large artery in
the brain (usually a major branch of the middle cerebral artery) to define the AIF used in the
analysis of the data. Traditionally, the magnitude of the native MR signal is logarithmically
transformed into relative units of gadolinium concentration. One difficulty with this
transformation is that at the peak of the bolus passage the signal may drop to the noise floor
making accurate estimates of concentration difficult (16,17).
The use of a single artery or several averaged artery measurements to represent the AIF for
the whole brain has its origin in the earliest work in tracer kinetic methods (18,19). For
quantitative PET, activity is measured directly from a peripheral arterial source. The
resulting time-activity curve is then decay-corrected and shifted in time to match the arrival
of PET activity in the brain. One difference between the two methods relates to the use of a
vascular tracer in DSC MR and a diffusible tracer in PET. Unlike DSC MR methods which
use the complete time-varying AIF, PET uses the convolution of the AIF with the response
function (a decaying mono-exponential). For these two reasons, flow measurements in DSC
MR are significantly more sensitive than PET to errors in modeled delay and dispersion as
well as to the exact shape of the AIF (20). Several investigators have explored the use of
local AIFs (LAIFs) to improve hemodynamic measurements (9,21,22) including the use of
voxel-specific AIFs using iterative blind-deconvolution (23,24).
In this paper we describe a variation of the standard tissue perfusion model (7) that provides
a local estimate of both the AIF and the residue curve for each voxel in the brain. The
parameters appearing in this model are estimated using Bayesian probability theory and
Markov-chain Monte Carlo methods (25). This approach has several advantages over
existing methods. Specifically, it eliminates the difficulty in selecting a single AIF by
estimating one for each voxel in the brain. It does not require numerical evaluation of the
logarithm of the signal nor does it require numerical deconvolution. The new method
estimates blood flow, blood volume and mean transit-time (MTT) as well as several
additional model parameters, some of which may provide useful clinical information (25).
Here we present the results of this method in comparison to PET measurements and to
traditional DSC MR measurements performed on the same day in a population of patients
with occlusive cerebrovascular disease (1,26).
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The magnetization observed by echo-planar imaging (EPI) from a bolus of contrast agent
may be represented as (27):
[1]
The detected signal, S(t), remains near a baseline value, S0, until the arrival at time t ≡ 0 of
the bolus, which is represented by the concentration time curve (CTC) in the tissue, CT(t). k
is an empirical constant of proportionality that varies with pulse sequence details as well as
details of the tissue microvasculature (6,7,27).
Conservation of mass and the fundamental central volume model of intravascular tracer
kinetics (19) specify the CTC in the tissue as a convolution of a voxel-dependent residue
function, R(t), with that voxel’s AIF, CA(t ):
[2]
The residue function depends on the details of the tissue microstructure. CBF is the local
cerebral blood flow. A general expression for the residue function may be expressed as
mono-exponential, as conventionally used in PET, multiplied by a power-series:
[3]
Model selection methods were used to investigate the need for the additional parameters, cn.
For the quality of our data, the model probabilities consistently favored the simplest model
with cn = 0 for all n > 0. Based on these calculations we used a mono-exponential residue
function, similar to (7).
The bolus passage of the tracer was described as having three characteristic phases: (1) an
initial rise in concentration with the main bolus arrival; (2) a subsequent rise in
concentration from recirculation and (3) a steady state circulation phase. The concentrations
of tracer in the main bolus as well as in the recirculation peak were each modeled with a
normalized gamma function:
[4]
The arrival time of the bolus is t0, and the phenomenological parameter α quantifies the
rapidity of arrival of contrast agent through the arterial network, while the parameter β
quantifies the rapidity of wash-out via the venous network. A constant multiplied by a
slowly rising exponential was used to model the gradual increase in the steady state amount
of contrast in the circulation, with γ representing this slow rise time. The model was not
sensitive to the value of γ, which was set to 0.05. The complete model for the AIF, at each
voxel position was
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with c0+c1+c2=1. In preliminary trials the posterior probabilities of models used
independent values for parameters {α1,β1,t01} and {α2,β2,t02} for the initial bolus and
recirculation, respectively. Bayesian model selection showed the data were more consistent
with a simpler model using a single set of dispersion parameters for both boluses
{α,β,t01,t02}, but independent arrival times t01 and,t02. Equations [3–5] were substituted into
Eq. [2] and integrals were evaluated analytically. The resulting closed-form expressions
were substituted into Eq. [1]. DSC MR provided time-dependent signals, S(t), for each
voxel. Parameter estimation was performed using Bayesian probability theory (25).
METHODS
Patient Selection
Subjects with paired hemodynamic PET and DSC MR studies were retrospectively
identified by review of laboratory records. These subjects were studied under two different
research protocols. All subjects provided written, informed consent in compliance with the
institutional review board of the Washington University School of Medicine. Both protocols
involved hemodynamic PET studies and DSC MR studies obtained on the same day for the
purposes of correlative analysis. One protocol was a sub-study of the Saint Louis Carotid
Occlusion Study, a prospective, blinded, natural-history study of the role of hemodynamics
in stroke risk for patients with atherosclerotic carotid artery occlusion (1,26). The other was
a protocol specifically written for the purpose of comparing MR and PET methods of CBF
measurement.
Fourteen subjects had complete PET and MR data suitable for analysis. Five and seven of
these subjects have been previously reported in two correlative analyses of different MR
methods (28,29). The primary inclusion criterion for the 14 subjects was angiographically
confirmed atherosclerotic occlusion of one proximal internal carotid artery. Both
asymptomatic and symptomatic subjects were enrolled. Symptoms included transient
ischemic neurologic deficits, transient monocular blindness, and mild to moderate
permanent ischemic neurologic deficits in the appropriate carotid artery territory.
Symptomatic subjects were studied at least one month after their last event. Exclusion
criteria were: inability to provide informed consent, inability to tolerate a supine position for
PET and MR imaging, pregnancy, and contraindications to MR imaging, such as
claustrophobia or MR-incompatible medical implants. PET and MR studies were obtained
on the same day without randomization, with the PET done first and the MRI following
within approximately an hour of completion of the PET study.
PET Methods
All PET scans were performed on an ECAT EXACT HR PET scanner (CTI PET Systems,
Knoxville, TN) run in 2D-mode with extended intersection septa. All subjects received
antecubital intravenous lines for receiving fluids and radioactive tracers. A radial-artery
catheter was placed and connected to an automated continuous blood-sampler that recorded
sampled activity in one-second bins. An attenuation scan was obtained. After venous
injection of 50 to 75 mCi of H2[15O] and following initial arrival of activity to the head, a
40-second acquisition was recorded. PET scans were reconstructed with filtered back-
projection using ramp filtering. The nominal spatial resolution of the detector array was 2.14
× 2.14 × 3.125 mm voxels. Back-projected PET activity counts were filtered with isotropic
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2D-Gaussian kernels at 10.0 mm full-width at half-maximum (FWHM). CBF was measured
using adaptations of the Kety autoradiographic method and permeability corrections (30,31).
CBF measurements with H2[15O] and quantitative PET underestimate true CBF at high
flows because of the incomplete permeability of the blood-brain barrier to water. Our
measurements were corrected for this finite permeability using permeability-surface area
products for water and butanol as described in reference (31). To the authors’ best
knowledge these corrections have previously been reported in only one prior correlative
study of perfusion measurements by PET and DSC MR (29).
MR Methods
All MR scans were performed on a 1.5 T Magnetom Vision scanner (Siemens, Erlangen,
Germany). All subjects received a large bore antecubital intravenous line appropriate for
delivering normal saline and gadolinium contrast agent. Anatomic studies were performed
with T1-weighted 3D fast low-angle shot gradient echo sequences (FLASH) with TR/TE =
18/8.4. Images were interpolated by the Vision console from 128 × 128 × 32 to 256 × 256 ×
32 voxels; the field-of-view was 256 × 256 × 64 mm. Immediately following an anatomic
study, a dynamic study was performed with single-shot gradient EPI with TR/TE = 800/54
and 90-degree flip angles. Images were interpolated from 128 × 128 × 8 to 256 × 256 × 8
voxels; the field of view was 240 × 240 × 48 mm. Axial EPI slices were contiguous and 6
mm thick. The image sequence was repeated 80 times for a total of 64 s. Approximately ten
seconds following the start of the EPI scan, a bolus of gadodiamide (Omniscan, Nycomed,
Zürich, Switzerland) was intravenously administered by power injection (Mallinckrodt, Inc.,
St. Louis, MO) at 5 mL/s to a final dose of 0.2 mmol/kg.
LAIF Methods
Posterior probabilities for all model parameters were computed voxel-by-voxel, using
complete EPI time-series with Bayesian probability theory (32). There were ten parameters
per voxel expressed in groups Ω, with voxel indices i:
[7]
Two parameters were CBF and MTT. Two parameters expressed the primary and
recirculation bolus arrival times, t01 and t02. The shape of the arriving bolus was described
by gamma-variate parameters α and β. Finally, the remaining parameters described the
baseline signal, S0, and the relative size of the terms in the AIF (c0, c1, and c2 in Eq. [5]).
Bayes’ theorem states that the posterior probability for the parameters, given data, Di, and
relevant background information, I, can be expressed as (32):
[8]
for which P(Di|Ωi,I) is the likelihood of the data given the model parameters, and P(Ωi|I) is
the prior probability for the model parameters. The prior probability was factored into
independent prior probabilities for each parameter:
[9]
All prior probabilities were assigned Gaussian distributions bounded by appropriate
physiologic ranges. The ranges selected for the parameters in our data set were: CBF (0–
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20.0) (dimensionless units that include the empirical constant k); MTT (0–20.0) s; t01 (0–
40.0) s; t02 (25.0–50.0) s; α (0–12.0), β (0–6.0); c’s (0–1.0). S0 was set to a narrow range
around the arbitrary baseline value produced by the MR scanner. The likelihood for the data
from a voxel, given the model parameters, P(Di |Ωi,I), is expressible as a marginal
probability when the standard deviations, σi, are removed using the sum and product rules:
[10]
Assigning Jeffreys’ prior probability to P(σi |I ) and assigning the Gaussian distribution to
P(Di |σi,Ωi,I), the marginal probability for the data may be written as the Student’s t-
distribution:
[11]
M is the number of data samples in time per voxel. Ωi is the total squared residual:
[12]
Eik is the measured signal and Sik is the model-estimated signal. The joint posterior
probability was estimated using Markov-chain Monte Carlo, Metropolis-Hastings sampling
and simulated annealing.
Computational implementations were custom written for the SGI Origin 2000 (Silicon
Graphics, Inc., Sunnyvale, CA). Using 32 processor-cores the computation time per image
slice, with extraparenchymal voxels masked out, was approximately 1.8 hours. Two of eight
axial slices were analyzed for fourteen of the subjects. Only one of eight axial slices was
analyzed in one of the subjects. The framework is currently distributed as Varian VNMRJ
packages (http://bayesiananalysis.wustl.edu,
http://www.varianinc.com/cgi-bin/nav?products/nmr/software/bayes). Recently we have
formulated a non-linear algorithm that decreases the computation time by greater than ten-
fold.
Deconvolution by MLEM
For comparison, perfusion was estimated using the method of maximum-likelihood
expectation-maximization (MLEM) originally reported by Vonken, et al. (33). All
computational details from the original implementation by Vonken, et al., were
implemented with two exceptions. One: all AIFs were expressed as absolute magnetizations
in time then smoothed using nonlinear least-squares regression of gamma-variate forms (Eq.
4). Two: the matrix representation of the AIF was forced to have the circulant-Toeplitz form
advocated by Wu, et al. (14). In a subset of the patient population described above, CBF
maps from MLEM and OSVD had indistinguishable correlations with PET CBF maps.
Limited tests of the sensitivity of our implementations of MLEM and OSVD revealed no
observable dependence of AIFs on time-shifts forwards or backwards in time. On an IBM
System ×3655 (IBM, Armonk, NY) running one processor-core the computation time per
image slice was approximately 0.8 hours. AIFs were manually selected from perivascular
voxels of M1-branches of the middle cerebral artery ipsilateral to patent carotid arteries.
After identifying vessel-dominant voxels by scrolling through EPI time frames, 8–10 voxels
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were selected in the vicinity of major vessel branches, but exterior to areas of deep signal
loss. Averaged AIFs were fitted with a gamma-variate using nonlinear least-squares (34).
PET MR Comparison
For each DSC-MR series, EPI time-frames were co-registered to a single, early frame which
best represented anatomical landmarks. 3D-FLASH series were aligned to the EPI spatial
reference. H2[15O] studies from PET were co-registered to the aligned 3D-FLASH. In some
cases, co-registration was improved by using native 3D-FLASH as an intermediate spatial
reference, e. g., PET was aligned to 3D-FLASH, then aligned PET was transformed to the
EPI spatial reference. The final common processing for all series was transformation to the
EPI reference. Linear, affine registration methods were used throughout. Minimization of
mutual information was added in cases for which affine methods yielded inadequate
alignment.
Three-dimensional-FLASH images were segmented into three to five clusters using fuzzy c-
mean clustering (Matlab 7, The Mathworks, Inc., Natick, MA). Each cluster was inspected
and categorized as a region of interest (ROI) for gray matter, white matter, cerebral-spinal
fluid (CSF), extra-dural tissues or bone. From EPI, voxels rich in arteries, those with the
greatest signal drop during bolus passage, were identified and assigned to a separate, arterial
ROI. All ROIs were graphically superimposed on co-registered 3D-FLASH, EPI, and PET
series and visually inspected to assure accuracy of placement. A board-certified
neuroradiologist (JSS) confirmed the accuracy of all placements.
Correlative analyses were performed using averages over contiguous blocks of in-plane,
native voxels in CBF maps. CBF maps from PET and DSC MR were matched for partial-
volume effects by using blocks of voxels sized to 10 × 10 × 6 mm3. Three-dimensional
Gaussian filtering was applied to native PET counts per validated methods prior to block-
averaging; filtering was never applied to MR CBF maps. High-resolution ROIs for arteries,
CSF and viable parenchyma were each block-averaged and normalized for use with block-
averaged CBF maps. Block-averaged ROIs were multiplied with block-averaged CBF maps.
For block-averaged ROIs with mixed tissues an approximate weighting scheme was used.
The averaged ROI voxel was assigned a real value from zero through unity, the relative
weight of the composite high-resolution tissue ROI voxels, each of which was always set to
zero or unity by the clustered segmentation scheme. Each block-average was analyzed with
scatter plots and Bland-Altman plots.
All images were viewed and analyzed using Analyze AVW (The Mayo Clinic, Rochester,
MN), FSL (http://www.fmrib.ox.ac.uk/fsl) (35), diplib (Quantitative Imaging Group, Delft
University of Technology, http://www.diplib.org) and Matlab (The Mathworks, Inc., Natick,
MA).
RESULTS
Representative plots from the parameter estimation phase of the Bayesian processing in a
single voxel are shown in Fig. 1. During the parameter estimation phase the search space
was explored using a Markov chain Monte-Carlo calculation and a population of parameter
values were created by sampling this calculation, and were used to compute mean and
standard deviation estimates for each parameter. Fig. 1a demonstrates the signal time curve
of this voxel in red, with the model generated from the parameters that maximized the joint
posterior probability in black, and the difference in green. Figs. 1b-1e show histograms of
this sampling for four of the estimated parameters. The coefficients of variation (standard
deviation divided by the mean) estimated from these plots is 1.4% for t01, 12.3% for α, 8.1%
for β and 13.2% for the CBF. Figs. 1f-1i illustrate sampling for pairs of parameters, which
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provide information on cross correlations between parameters in the model. The posterior
probability density functions for t01 versus CBF and α versus CBF from Figs. 1g and 1i are
consistent with no cross correlation between the parameters. Although not shown, there was
also no cross correlation between CBF and β.
Details for a single patient from the study cohort are shown in Fig. 2. This 37 year-old
female had a history of lacunar infarcts and infarction of the territory of the right middle-
cerebral artery approximately one year prior to imaging. Cerebral angiography performed
shortly before her MR and PET studies revealed the right internal carotid artery to be
occluded. The T1-weighted 3D-FLASH image shows the sequela of the patient’s ischemic
stroke, visible in the right hemisphere as encephalomalacia (radiologic display convention).
The 3D-FLASH image was the reference for segmentation of ROIs and co-registration of
PET images and is shown co-registered to EPI. Fig. 2 shows maps of hemodynamic
parameters obtained by MR LAIF: CBF, CBV, MTT, α, β, t01, and c1. The right-frontal area
of infarction and hemispheric asymmetries are discernable in all parameter maps except the
map of α. This finding represents a uniform rate of in-flow of contrast to both hemispheres,
as may be expected from collateral blood supply to the hemisphere ipsilateral to chronic
carotid occlusion. However, the map of β is asymmetric between hemispheres, likely
representing slower venous outflow in the affected hemisphere. The map of t0, the delay in
bolus arrival, is dramatically asymmetric between hemispheres showing delayed arrival in
the hemisphere with complete carotid occlusion. The map of c1 demonstrates increases in
the affected hemisphere that correspond to decreases in the recirculation of contrast agent;
the map corresponds anatomically with regions of decreased β. The affected hemisphere also
exhibits mildly decreased CBF, mildly decreased CBV and increased MTT,
Representative blood-flow maps for three subjects from the study cohort are shown in Fig.
3. The variability of CBF maps between PET, MR LAIF and MR MLEM, with and without
block-averaging of native voxels is illustrated across columns. The variability of perfusion
maps between human subjects is illustrated by the rows. Statistical analyses required
comparison of perfusion maps from MR and PET with matched spatial resolutions. The
results of block-averaging are illustrated across the columns of Fig. 3. Not shown are the
block-averaged ROIs used to exclude artery-rich voxels, CSF-rich voxels, voxels from
extra-dural tissues, and background extracranial voxels.
Fig. 4 illustrates graphically for a single patient the association of quantitative PET CBF to
(a) MR LAIF CBF and (b) MR MLEM CBF. Each plotted point represents the average over
a contiguous block of voxels; MR and PET voxels were each sized to 10 × 10 × 6 mm.
Arbitrary units for LAIF and MLEM indicate that the value of scaling coefficient k is
unknown. Both artery-rich voxels, plotted in red, and CSF voxels plotted in green confound
the analysis of CBF as measured by either MR method. For the single, representative
patient, the squared Pearson correlation coefficient of PET with LAIF is 0.491. For PET
with MLEM it is 0.446. The graphical analysis of Bland and Altman (36) for comparing
alternative measurement methods is shown for (c) the deviation of standardized first
moments of LAIF CBF from PET CBF and (d) the deviation of standardized first moments
of MLEM CBF from PET CBF. Standardized moments show scale-invariant trends. Similar
results were obtained for plots of percentage of the mean (37).
Fig. 5 illustrates graphically for all 14 subjects the pooled association of PET CBF to (a) MR
LAIF CBF and (b) MR MLEM CBF. Each plotted point represents a single block-averaged
voxel. ROI masks were employed to exclude artery-rich voxels and CSF-rich voxels. The
squared Pearson correlation coefficient for PET with LAIF is 0.314. For PET with MLEM,
it is 0.246. The Bland and Altman analysis is shown for the pooled patient data for (c) the
deviation of LAIF CBF from PET CBF and (d) the deviation of MLEM CBF from PET
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CBF. The scaling coefficient k is a priori not universal and constant for each patient, as
illustrated previously by Takasawa (37) as well as Figs 5a and 5b. For any single patient,
correlations are strong between LAIF and PET, and between MLEM and PET, as detailed in
Table 1. The mean value of k over 14 patients was calculated to be 0.054 ± 0.0089 for LAIF,
and 0.0068 ± 0.0013 for MLEM. Relative standard errors in k were 16% for LAIF and 19%
for MLEM, suggesting that an empirically determined, constant k may be useful in practice.
Variation of k corresponds predictably with decreased correlation between MR and PET, for
which case regressed slopes tend toward zero.
DISCUSSION
The LAIF method has several advantages over current techniques. The selection of a single,
global AIF, which can be challenging in a DSC MR study, is obviated in LAIF. During
contrast-bolus injection the signal in large vessels will often saturate to the noise floor
making accurate estimation of the AIF difficult (16). It should be noted that this effect is
unique to MR and is not shared by AIFs used in perfusion imaging by PET and CT. Many
investigators avoid voxels which are suspected to lie within or very near large vessels
because of confounding effects from signal saturation. These criteria have been codified in
automated AIF selection methods, which employ statistical clustering algorithms to
segregate tissue concentration curves into groups with similar temporal shapes (38). A
cluster is sought which best satisfies criteria such as: large area under the curve of the CTC,
early arrival, rapidly and smoothly rising peak concentrations and quick wash-out. Clusters
are averaged, filtered and often fitted with a gamma-variate curve for use as the global AIF.
Global AIF selection methods run the risk of incorporating some tissue voxels into the AIF
(39). The LAIF method models AIF saturation, using the assumption of a gamma-variate
shape, by directly using the MR signal Eq. [1] without resorting to a logarithm
transformation to concentrations.
Selection of a local AIF has the advantage of better representing the arterial supply to the
brain in subjects with acute or chronic hemodynamic impairment. Using a single AIF
provides accurate results in perfusion imaging with quantitative PET since PET uses the
convolution integral of the AIF rather than its timecourse. Additionally, PET uses a
diffusible tracer for which the residue curve is an exponential that requires the estimation of
a single transit-time parameter. Compared to the use of AIFs in PET, the use of AIFs for
DSC MR is significantly more sensitive to the effects of delay and dispersion.
Underestimations as well as overestimations of regional CBF have been observed and
attributed to the delay, dispersion and mixing with tissue voxels that result from the
construction of a global AIF (14,39,40). Delay and dispersion in the AIF are hallmarks of
hemodynamic impairment; thus DSC MR with deconvolution may compound inaccuracies
in this clinical scenario. The significant variations from normal cerebral hemodynamics in
our patient cohort bring out these overestimations and underestimations in Fig. 5. Delay, but
not dispersion, effects may be substantially mitigated by ensuring that numerical
deconvolutions are performed with circulant-Toeplitz kernels, thereby preserving temporal
causality (14). There is great variability in perfusion measurements with variations in the
choice of AIFs, as has been shown in numerous studies (39,41,42). The LAIF method avoids
the complications of delay and dispersion from a distal AIF.
An additional benefit of the LAIF model is the estimation of new parameters that may
provide additional valuable clinical information. These parameters include the arrival time
for the main bolus and the recirculation peak (t01 and t02), and the local AIF gamma-variate
parameters α and β. The difference between t01 and t02 is an estimate of the circulation time
of the bolus and may provide some information on the cardiac output of the subject. Since α
determines the rapidity of the rise of the AIF it may provide information on the arterial
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supply to the voxel. A slow rise time may indicate local cerebrovascular disease, or
collateral supply. The β parameter determines the descending portion of the AIF and thus
may provide information on the capillary and venous drainage from the voxel in question.
Delayed drainage of contrast, could possibly indicate venous congestion due to venous
thrombosis or a nearby arterial-venous anomaly.
Within the limitation of our assumption of certain shapes for the AIF and residue curves, the
LAIF method avoids the need to perform numerical deconvolution, which is inherently
unstable, especially with non-Gaussian noise. Various methods have been developed to
overcome this problem: truncating the rank of the deconvolution kernel by SVD (14),
Tikhonov regularization (8), and also regularization by parameterized reduction of
oscillations in the residue function (40,43). The LAIF model makes the assumption of
analytical curve shapes for the tissue concentration curve and the residue curve and then,
using these analytical curves, performs an analytical convolution. The parameter estimation
then relies on Bayesian probability theory and Markov-chain Monte Carlo and does not
require computation of deconvolutions, thus avoiding these issues altogether.
It should be noted that when substituting Eq. [2] into [1] the CBF is multiplied by the
unknown constant k, and without a way to determine k only relative perfusion can be
evaluated. In this study we show that PET perfusion data may be used to calibrate this
constant for a population of patients with chronic, cerebral hemodynamic impairment.
Although theoretically k varies across different tissue types and details of pulse sequences,
in practice, a single value may be adequate for the MR CBF ranges of clinical significance.
The determination of this constant may provide a scaling factor to better quantify flow
measurements with DSC MR.
CONCLUSION
We present a tissue perfusion model that provides a local estimate of both the AIF and the
residue function for each voxel in brain perfusion image. The parameters of the model are
estimated using Bayesian probability theory and Markov-chain Monte Carlo. This technique
has several advantages over existing methods. It obviates the difficulties of determining a
single, global AIF. It does not require numerical deconvolution. In addition to estimating
CBF, CBV and MTT, several novel model parameters are estimated, which may provide
useful clinical information.
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ABBREVIATIONS
AIF Arterial input function
CBF Cerebral blood flow
CBV Cerebral blood volume
CTC Concentration time curve
DSC Dynamic susceptibility contrast
EPI Echo-planar imaging
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FLASH Fast, low-angle shot
FWHM Full-width at half-maximum
LAIF Localized arterial input function
MLEM Maximum-likelihood expectation-maximization
MTT Mean transit time
MR Magnetic resonance
OSVD Oscillation-minimized singular-value decomposition
PET Positron emission tomography
ROI Region of interest
STLCOS Saint Louis Carotid Occlusion Study
SVD,SSVD Standard singular-value decomposition
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Plots describe the parameter estimation phase of Bayesian processing for a single voxel.
Parameter estimates were produced by sampling the Markov chain for the data model. (a)
The observed magnetization vs. time in the selected voxel is plotted in red. Superposed in
black is the model generated from parameters that maximized the joint posterior probability.
The difference curve is plotted in green. Histograms of samples of the parameters (b) t0, (c)
α, (d) β and (e) CBF display estimated probabilities along the vertical axes. Scatter plots of
parameter pairs (f) t0 versus α; (g) t0 versus CBF; (h) α versus β; (i) α versus CBF; further
details in Results.
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T1-weighted MR study and maps of hemodynamic parameters from the LAIF method for a
patient with a history of lacunar infarcts and cerebral vascular accident involving the right
middle-cerebral artery. CBF, CBV and MTT were estimated with LAIF. Additional tracer-
kinetic parameters uniquely provided by LAIF are: α, which characterizes the rapidity of
inflow of contrast agent in the AIF; β, which characterizes the rate of outflow of contrast
agent in the AIF; t0, the time of arrival of the contrast agent tracer during its first passage
through the cerebral circulation; and c1, the relative weight of the concentration of the first-
passage of contrast agent to the time-integral of concentration.
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CBF maps from MR LAIF and PET for three representative patients. Column (a) shows
anatomical references. Columns (b—d) show CBF maps with native spatial resolutions for
MR and PET. Columns (e—g) show results of block averaging to 10 × 10 × 6 mm2, used to
match differing spatial resolutions.
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Analysis of correlations between PET CBF and MR CBF for a representative patient (patient
1). Plotted points are block-averages of parenchyma voxels only. Blocks containing a
majority of CSF or artery-rich voxels are excluded. (a) Scatter plot of PET CBF vs. MR
LAIF CBF. Linear regression yielded: CBFLAIF = −0.464 + 0.0326 CBFPET, which is
plotted as a bold line. The 95% confidence interval for the fitted line with non-simultaneous
is plotted with dashed lines. The squared Pearson product-moment correlation coefficient is
0.493. (b) Similar plot of PET CBF vs. MR MLEM CBF. Regression yielded: CBFMLEM =
0.0521+ 0.00282 CBFPET. The squared correlation coefficient is 0.446. For Bland-Altman
analysis of systematic trends the standardized first-moment of CBF values was used: fμσ. (c)
Differences between first-moments of MR LAIF CBF and matching PET CBF are plotted
with respect to the unbiased estimate of the true first-moment of CBF, the average of first
moments of MR LAIF CBF and matching PET CBF. The 95% confidence intervals for
differences are ±1.51. (d) The difference between first moments of MR MLEM CBF and
matching PET CBF is plotted against the unbiased estimate. The 95% confidence intervals
for differences are ±1.60.
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The analysis of correlations described in Fig. 4 was applied to pooled PET and MR
measurement from fourteen patients. Plotted points are block-averages of parenchyma
voxels with each patient assigned a unique grey-value. (a) Scatter plot of PET CBF vs. MR
LAIF CBF. For each patient, linear regression results are listed in Table 1; for each patient,
regression and 95% confidence intervals are plotted with bold and dashed lines respectively.
Linear regression over pooled data from all 14 patients yielded: CBFLAIF = 1.03 + 0.0483
CBFPET, which is not plotted. The squared correlation coefficient is 0.314. (b) Plot of PET
CBF vs. MR MLEM CBF. For each patient linear regression results are listed in Table 1.
Pooled regression yielded: CBFMLEM = 0.155 + 0.00546 CBFPET, which is not plotted. The
squared correlation coefficient is 0.246. (c) Bland-Altman analyses of the differences
between the first moments of MR LAIF CBF and matched PET CBF vs. the unbiased
estimate of the true first-moment of CBF, the average of first moments of MR LAIF CBF
and matching PET CBF. For each patient, 95% confidence intervals are plotted with dashed
lines. Ninety-five percent confidence intervals for pooled mean differences from all 14
patients are ±1.69, which is not shown. (d) Bland-Altman analyses of the differences
between the first moments of MR MLEM CBF and matched PET CBF vs. the unbiased
estimate of the true first-moment of CBF. Ninety-five percent confidence intervals for
pooled mean differences are ±1.59.
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Table 1
Scaling factors, k, for MR LAIF and MR MLEM methods. The square of Pearson’s correlation coefficients for
regressions, r2, are also shown.
Patient kLAIF r2LAIF kMLEM r2MLEM
1* 0.033 0.49 0.0028 0.446
2 0.079 0.53 0.0074 0.601
3 0.034 0.28 0.0039 0.315
4 0.106 0.53 0.0067 0.656
5 0.060 0.40 0.0072 0.385
6 0.034 0.65 0.0051 0.753
7 0.084 0.68 0.0192 0.843
8 0.036 0.22 0.0013 0.050
9 0.056 0.47 0.0059 0.539
10 0.129 0.69 0.0167 0.819
11 0.030 0.12 0.0032 0.116
12 0.029 0.66 0.0056 0.467
13 0.019 0.31 0.0067 0.388
14 0.029 0.11 0.0042 0.223
*
data from patient 1 are shown in detail in Fig. 4.
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